25 XP   0   0   10

Gufic Biosciences Limited
Buy, Hold or Sell?

Let's analyse Gufic together

PenkeI guess you are interested in Gufic Biosciences Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Gufic Biosciences Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Gufic Biosciences Limited

I send you an email if I find something interesting about Gufic Biosciences Limited.

Quick analysis of Gufic (30 sec.)










What can you expect buying and holding a share of Gufic? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR34.68
Expected worth in 1 year
INR66.07
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR31.81
Return On Investment
11.3%

For what price can you sell your share?

Current Price per Share
INR282.50
Expected price per share
INR238.02 - INR325.85
How sure are you?
50%

1. Valuation of Gufic (5 min.)




Live pricePrice per Share (EOD)

INR282.50

Intrinsic Value Per Share

INR-136.01 - INR-57.36

Total Value Per Share

INR-101.33 - INR-22.68

2. Growth of Gufic (5 min.)




Is Gufic growing?

Current yearPrevious yearGrowGrow %
How rich?$41.7m$32.2m$9.4m22.6%

How much money is Gufic making?

Current yearPrevious yearGrowGrow %
Making money$9.5m$11.5m-$1.9m-20.2%
Net Profit Margin11.5%12.3%--

How much money comes from the company's main activities?

3. Financial Health of Gufic (5 min.)




What can you expect buying and holding a share of Gufic? (5 min.)

Welcome investor! Gufic's management wants to use your money to grow the business. In return you get a share of Gufic.

What can you expect buying and holding a share of Gufic?

First you should know what it really means to hold a share of Gufic. And how you can make/lose money.

Speculation

The Price per Share of Gufic is INR282.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gufic.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gufic, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR34.68. Based on the TTM, the Book Value Change Per Share is INR7.85 per quarter. Based on the YOY, the Book Value Change Per Share is INR9.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gufic.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.100.0%0.100.0%0.110.0%0.060.0%0.040.0%
Usd Book Value Change Per Share0.090.0%0.090.0%0.110.0%0.070.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.100.0%0.100.0%0.120.0%0.070.0%0.040.0%
Usd Price Per Share2.24-2.24-2.99-1.62-1.09-
Price to Earnings Ratio23.45-23.45-26.05-26.28-37.10-
Price-to-Total Gains Ratio23.44-23.44-25.85-24.24-47.07-
Price to Book Ratio5.37-5.37-9.28-7.28-9.05-
Price-to-Total Gains Ratio23.44-23.44-25.85-24.24-47.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.39
Number of shares294
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.090.07
Usd Total Gains Per Share0.100.07
Gains per Quarter (294 shares)28.0520.93
Gains per Year (294 shares)112.2183.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1111110218374
232212142166158
343323263248242
464434384331326
575545505414410
696646625497494
7107757746580578
8128868867663662
9139979988745746
1015110711109828830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.01.093.8%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%

Fundamentals of Gufic

About Gufic Biosciences Limited

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. The company manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. It manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, the company offers spark, criti care, criticare life, and ferticare pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-03-09 21:40:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Gufic Biosciences Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Gufic earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 11.5% means that ₹0.12 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Gufic Biosciences Limited:

  • The MRQ is 11.5%. The company is making a huge profit. +2
  • The TTM is 11.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.5%TTM11.5%0.0%
TTM11.5%YOY12.3%-0.8%
TTM11.5%5Y9.2%+2.4%
5Y9.2%10Y6.6%+2.6%
1.1.2. Return on Assets

Shows how efficient Gufic is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • 9.3% Return on Assets means that Gufic generated ₹0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Gufic Biosciences Limited:

  • The MRQ is 9.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.3%TTM9.3%0.0%
TTM9.3%YOY18.4%-9.1%
TTM9.3%5Y10.7%-1.4%
5Y10.7%10Y7.9%+2.8%
1.1.3. Return on Equity

Shows how efficient Gufic is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • 22.9% Return on Equity means Gufic generated ₹0.23 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Gufic Biosciences Limited:

  • The MRQ is 22.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 22.9%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ22.9%TTM22.9%0.0%
TTM22.9%YOY35.6%-12.7%
TTM22.9%5Y27.6%-4.7%
5Y27.6%10Y24.7%+3.0%

1.2. Operating Efficiency of Gufic Biosciences Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Gufic is operating .

  • Measures how much profit Gufic makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 16.6% means the company generated ₹0.17  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Gufic Biosciences Limited:

  • The MRQ is 16.6%. The company is operating efficient. +1
  • The TTM is 16.6%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ16.6%TTM16.6%0.0%
TTM16.6%YOY16.7%-0.1%
TTM16.6%5Y14.5%+2.2%
5Y14.5%10Y11.5%+3.0%
1.2.2. Operating Ratio

Measures how efficient Gufic is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are ₹0.84 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 0.837. The company is less efficient in keeping operating costs low.
  • The TTM is 0.837. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.837TTM0.8370.000
TTM0.837YOY0.835+0.002
TTM0.8375Y0.862-0.024
5Y0.86210Y0.887-0.026

1.3. Liquidity of Gufic Biosciences Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Gufic is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.61 means the company has ₹1.61 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 1.610. The company is able to pay all its short-term debts. +1
  • The TTM is 1.610. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.610TTM1.6100.000
TTM1.610YOY1.715-0.105
TTM1.6105Y1.468+0.143
5Y1.46810Y1.317+0.151
1.3.2. Quick Ratio

Measures if Gufic is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.94 means the company can pay off ₹0.94 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 0.938. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.938. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.938TTM0.9380.000
TTM0.938YOY1.177-0.239
TTM0.9385Y0.910+0.028
5Y0.91010Y0.752+0.158

1.4. Solvency of Gufic Biosciences Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Gufic assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gufic to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.60 means that Gufic assets are financed with 59.6% credit (debt) and the remaining percentage (100% - 59.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 0.596. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.596. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.596TTM0.5960.000
TTM0.596YOY0.484+0.112
TTM0.5965Y0.620-0.024
5Y0.62010Y0.695-0.075
1.4.2. Debt to Equity Ratio

Measures if Gufic is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 147.6% means that company has ₹1.48 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 1.476. The company is able to pay all its debts with equity. +1
  • The TTM is 1.476. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.476TTM1.4760.000
TTM1.476YOY0.937+0.539
TTM1.4765Y1.820-0.344
5Y1.82010Y2.589-0.769

2. Market Valuation of Gufic Biosciences Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Gufic generates.

  • Above 15 is considered overpriced but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 23.45 means the investor is paying ₹23.45 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Gufic Biosciences Limited:

  • The EOD is 35.542. Based on the earnings, the company is overpriced. -1
  • The MRQ is 23.451. Based on the earnings, the company is fair priced.
  • The TTM is 23.451. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD35.542MRQ23.451+12.091
MRQ23.451TTM23.4510.000
TTM23.451YOY26.053-2.602
TTM23.4515Y26.279-2.827
5Y26.27910Y37.097-10.819
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Gufic Biosciences Limited:

  • The EOD is -13.226. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.727. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.727. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.226MRQ-8.727-4.499
MRQ-8.727TTM-8.7270.000
TTM-8.727YOY159.624-168.351
TTM-8.7275Y31.077-39.804
5Y31.07710Y-6.829+37.907
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Gufic is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 5.37 means the investor is paying ₹5.37 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Gufic Biosciences Limited:

  • The EOD is 8.145. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.374. Based on the equity, the company is overpriced. -1
  • The TTM is 5.374. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.145MRQ5.374+2.771
MRQ5.374TTM5.3740.000
TTM5.374YOY9.278-3.904
TTM5.3745Y7.281-1.907
5Y7.28110Y9.051-1.770
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Gufic Biosciences Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--7.8477.8470%9.542-18%5.870+34%3.245+142%
Book Value Per Share--34.68434.6840%26.837+29%19.178+81%11.441+203%
Current Ratio--1.6101.6100%1.715-6%1.468+10%1.317+22%
Debt To Asset Ratio--0.5960.5960%0.484+23%0.620-4%0.695-14%
Debt To Equity Ratio--1.4761.4760%0.937+57%1.820-19%2.589-43%
Dividend Per Share--0.1040.1040%0.092+13%0.064+63%0.051+103%
Eps--7.9487.9480%9.557-17%5.273+51%3.048+161%
Free Cash Flow Per Share---21.359-21.3590%1.560-1469%-2.513-88%-1.363-94%
Free Cash Flow To Equity Per Share--2.0062.0060%1.251+60%0.630+219%0.352+470%
Gross Profit Margin--0.9250.9250%0.965-4%0.922+0%0.871+6%
Intrinsic Value_10Y_max---57.364--------
Intrinsic Value_10Y_min---136.012--------
Intrinsic Value_1Y_max---2.314--------
Intrinsic Value_1Y_min---6.578--------
Intrinsic Value_3Y_max---9.570--------
Intrinsic Value_3Y_min---25.989--------
Intrinsic Value_5Y_max---19.981--------
Intrinsic Value_5Y_min---52.072--------
Market Cap28328535000.000+34%18691819200.00018691819200.0000%24969222000.000-25%13514466060.000+38%9106746570.000+105%
Net Profit Margin--0.1150.1150%0.123-6%0.092+26%0.066+76%
Operating Margin--0.1660.1660%0.1670%0.145+15%0.115+45%
Operating Ratio--0.8370.8370%0.835+0%0.862-3%0.887-6%
Pb Ratio8.145+34%5.3745.3740%9.278-42%7.281-26%9.051-41%
Pe Ratio35.542+34%23.45123.4510%26.053-10%26.279-11%37.097-37%
Price Per Share282.500+34%186.400186.4000%249.000-25%134.770+38%90.815+105%
Price To Free Cash Flow Ratio-13.226-52%-8.727-8.7270%159.624-105%31.077-128%-6.829-22%
Price To Total Gains Ratio35.529+34%23.44323.4430%25.847-9%24.244-3%47.072-50%
Quick Ratio--0.9380.9380%1.177-20%0.910+3%0.752+25%
Return On Assets--0.0930.0930%0.184-50%0.107-13%0.079+18%
Return On Equity--0.2290.2290%0.356-36%0.276-17%0.247-7%
Total Gains Per Share--7.9517.9510%9.633-17%5.933+34%3.296+141%
Usd Book Value--41736984.00041736984.0000%32294148.000+29%23077550.400+81%13767056.400+203%
Usd Book Value Change Per Share--0.0940.0940%0.114-18%0.070+34%0.039+142%
Usd Book Value Per Share--0.4160.4160%0.322+29%0.230+81%0.137+203%
Usd Dividend Per Share--0.0010.0010%0.001+13%0.001+63%0.001+103%
Usd Eps--0.0950.0950%0.115-17%0.063+51%0.037+161%
Usd Free Cash Flow---25702548.000-25702548.0000%1877100.000-1469%-3023839.200-88%-1640499.600-94%
Usd Free Cash Flow Per Share---0.256-0.2560%0.019-1469%-0.030-88%-0.016-94%
Usd Free Cash Flow To Equity Per Share--0.0240.0240%0.015+60%0.008+219%0.004+470%
Usd Market Cap339942420.000+34%224301830.400224301830.4000%299630664.000-25%162173592.720+38%109280958.840+105%
Usd Price Per Share3.390+34%2.2372.2370%2.988-25%1.617+38%1.090+105%
Usd Profit--9564576.0009564576.0000%11500812.000-17%6367706.400+50%3702027.600+158%
Usd Revenue--82874496.00082874496.0000%93498672.000-11%63983899.200+30%44315883.600+87%
Usd Total Gains Per Share--0.0950.0950%0.116-17%0.071+34%0.040+141%
 EOD+5 -3MRQTTM+0 -0YOY+11 -255Y+29 -710Y+30 -6

3.2. Fundamental Score

Let's check the fundamental score of Gufic Biosciences Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1535.542
Price to Book Ratio (EOD)Between0-18.145
Net Profit Margin (MRQ)Greater than00.115
Operating Margin (MRQ)Greater than00.166
Quick Ratio (MRQ)Greater than10.938
Current Ratio (MRQ)Greater than11.610
Debt to Asset Ratio (MRQ)Less than10.596
Debt to Equity Ratio (MRQ)Less than11.476
Return on Equity (MRQ)Greater than0.150.229
Return on Assets (MRQ)Greater than0.050.093
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Gufic Biosciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.784
Ma 20Greater thanMa 50297.505
Ma 50Greater thanMa 100319.316
Ma 100Greater thanMa 200315.590
OpenGreater thanClose286.750
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets8,611,595
Total Liabilities5,133,513
Total Stockholder Equity3,478,082
 As reported
Total Liabilities 5,133,513
Total Stockholder Equity+ 3,478,082
Total Assets = 8,611,595

Assets

Total Assets8,611,595
Total Current Assets4,641,086
Long-term Assets3,970,509
Total Current Assets
Cash And Cash Equivalents 286,019
Short-term Investments 180,848
Net Receivables 2,056,701
Inventory 1,834,575
Other Current Assets 282,943
Total Current Assets  (as reported)4,641,086
Total Current Assets  (calculated)4,641,086
+/-0
Long-term Assets
Property Plant Equipment 3,284,788
Intangible Assets 6,788
Other Assets 671,090
Long-term Assets  (as reported)3,970,509
Long-term Assets  (calculated)3,962,666
+/- 7,843

Liabilities & Shareholders' Equity

Total Current Liabilities2,882,075
Long-term Liabilities2,251,438
Total Stockholder Equity3,478,082
Total Current Liabilities
Short-term Debt 1,273,036
Short Long Term Debt 1,207,278
Accounts payable 1,302,646
Other Current Liabilities 125,048
Total Current Liabilities  (as reported)2,882,075
Total Current Liabilities  (calculated)3,908,008
+/- 1,025,933
Long-term Liabilities
Long term Debt 1,906,793
Capital Lease Obligations 227,857
Other Liabilities 182,546
Long-term Liabilities  (as reported)2,251,438
Long-term Liabilities  (calculated)2,317,196
+/- 65,758
Total Stockholder Equity
Common Stock96,945
Retained Earnings 2,686,374
Accumulated Other Comprehensive Income 708,234
Total Stockholder Equity (as reported)3,478,082
Total Stockholder Equity (calculated)3,491,553
+/- 13,471
Other
Capital Stock96,945
Cash and Short Term Investments 466,867
Common Stock Shares Outstanding 96,964
Current Deferred Revenue181,345
Liabilities and Stockholders Equity 8,611,595
Net Debt 3,055,909
Net Invested Capital 6,592,153
Net Tangible Assets 3,471,294
Net Working Capital 1,759,011
Property Plant and Equipment Gross 3,284,788
Short Long Term Debt Total 3,341,928



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-31
> Total Assets 
489,809
473,526
555,565
605,979
741,278
895,764
1,111,456
1,272,878
1,521,992
1,778,193
2,360,743
2,795,397
3,562,407
3,920,610
5,214,017
8,611,595
8,611,5955,214,0173,920,6103,562,4072,795,3972,360,7431,778,1931,521,9921,272,8781,111,456895,764741,278605,979555,565473,526489,809
   > Total Current Assets 
327,847
316,527
384,243
432,677
498,023
523,910
693,043
917,481
1,196,490
1,441,614
1,970,369
2,325,135
2,634,806
2,605,828
3,207,540
4,641,086
4,641,0863,207,5402,605,8282,634,8062,325,1351,970,3691,441,6141,196,490917,481693,043523,910498,023432,677384,243316,527327,847
       Cash And Cash Equivalents 
13,420
4,864
10,800
9,475
9,627
12,783
25,414
62,063
61,590
55,259
36,712
36,614
41,840
62,014
116,081
286,019
286,019116,08162,01441,84036,61436,71255,25961,59062,06325,41412,7839,6279,47510,8004,86413,420
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
36,983
-67,044
-25
69,765
149,631
180,848
180,848149,63169,765-25-67,04436,9830000000000
       Net Receivables 
0
0
0
0
0
0
395,108
473,061
556,895
530,749
810,216
1,340,018
1,471,577
1,598,692
1,935,750
2,056,701
2,056,7011,935,7501,598,6921,471,5771,340,018810,216530,749556,895473,061395,108000000
       Inventory 
115,225
107,065
103,553
127,667
169,094
199,959
261,154
368,014
502,631
630,163
938,828
942,846
1,091,977
944,046
1,155,669
1,834,575
1,834,5751,155,669944,0461,091,977942,846938,828630,163502,631368,014261,154199,959169,094127,667103,553107,065115,225
       Other Current Assets 
199,202
204,598
269,890
295,536
319,302
311,168
406,475
487,404
632,269
756,192
994,829
5,657
29,412
1,076
40
282,943
282,943401,07629,4125,657994,829756,192632,269487,404406,475311,168319,302295,536269,890204,598199,202
   > Long-term Assets 
161,962
156,999
171,323
173,301
243,255
371,854
418,413
355,397
325,502
336,579
390,374
470,262
927,601
1,314,782
2,006,477
3,970,509
3,970,5092,006,4771,314,782927,601470,262390,374336,579325,502355,397418,413371,854243,255173,301171,323156,999161,962
       Property Plant Equipment 
142,109
141,452
158,999
164,910
183,350
297,533
301,861
250,752
221,254
219,900
242,643
356,259
794,542
1,184,569
1,897,527
3,284,788
3,284,7881,897,5271,184,569794,542356,259242,643219,900221,254250,752301,861297,533183,350164,910158,999141,452142,109
       Goodwill 
0
0
0
0
0
0
0
0
0
0
280
224
210
0
0
0
0002102242800000000000
       Long Term Investments 
0
0
0
0
0
0
93
93
93
50
50
50
0
0
0
0
0000505050939393000000
       Intangible Assets 
0
0
0
0
0
0
425
319
213
108
1,080
3,440
5,360
4,451
6,102
6,788
6,7886,1024,4515,3603,4401,080108213319425000000
       Long-term Assets Other 
19,853
15,547
12,324
8,391
59,905
74,321
116,552
104,645
104,248
116,679
121,162
378
123,058
-3
352,735
661,426
661,426352,735-3123,058378121,162116,679104,248104,645116,55274,32159,9058,39112,32415,54719,853
> Total Liabilities 
327,181
307,059
381,330
421,613
546,136
671,825
849,369
1,001,879
1,182,404
1,329,125
1,825,584
2,041,918
2,603,867
2,186,244
2,522,838
5,133,513
5,133,5132,522,8382,186,2442,603,8672,041,9181,825,5841,329,1251,182,4041,001,879849,369671,825546,136421,613381,330307,059327,181
   > Total Current Liabilities 
156,483
137,831
186,562
189,040
458,683
436,779
603,103
836,095
1,036,761
1,152,740
1,672,575
1,863,433
2,245,672
1,636,624
1,869,821
2,882,075
2,882,0751,869,8211,636,6242,245,6721,863,4331,672,5751,152,7401,036,761836,095603,103436,779458,683189,040186,562137,831156,483
       Short-term Debt 
2,022
2,682
2,693
1,247
153,197
137,368
147,664
179,042
351,791
500,783
713,753
864,742
962,385
232,883
166,612
1,273,036
1,273,036166,612232,883962,385864,742713,753500,783351,791179,042147,664137,368153,1971,2472,6932,6822,022
       Short Long Term Debt 
0
0
0
0
0
0
334,040
34,111
27,550
500,156
713,054
864,363
928,069
163,243
65,992
1,207,278
1,207,27865,992163,243928,069864,363713,054500,15627,55034,111334,040000000
       Accounts payable 
88,404
80,591
134,024
147,193
222,156
207,177
317,963
495,333
894
437,387
745,480
778,051
1,086,228
1,130,286
1,409,512
1,302,646
1,302,6461,409,5121,130,2861,086,228778,051745,480437,387894495,333317,963207,177222,156147,193134,02480,59188,404
       Other Current Liabilities 
66,057
54,557
49,845
40,600
83,330
92,234
137,476
161,720
684,076
651,957
187,444
27
49
1
123,866
125,048
125,048123,86614927187,444651,957684,076161,720137,47692,23483,33040,60049,84554,55766,057
   > Long-term Liabilities 
170,698
169,228
194,768
232,573
87,453
235,046
246,266
165,784
145,643
176,385
153,009
178,485
358,195
549,620
653,017
2,251,438
2,251,438653,017549,620358,195178,485153,009176,385145,643165,784246,266235,04687,453232,573194,768169,228170,698
       Long term Debt Total 
0
0
0
0
0
0
0
0
74,579
66,232
83,192
113,117
179,235
382,489
477,261
0
0477,261382,489179,235113,11783,19266,23274,57900000000
       Other Liabilities 
0
0
0
0
0
0
97,387
50,750
69,003
63,355
70,280
65,368
126,768
167,132
175,754
182,546
182,546175,754167,132126,76865,36870,28063,35569,00350,75097,387000000
> Total Stockholder Equity
162,628
166,467
174,235
184,366
195,142
223,939
262,087
270,999
339,588
449,068
535,159
753,479
958,540
1,734,366
2,691,179
3,478,082
3,478,0822,691,1791,734,366958,540753,479535,159449,068339,588270,999262,087223,939195,142184,366174,235166,467162,628
   Common Stock
77,350
77,350
77,350
77,350
77,350
77,350
77,350
77,350
77,350
77,350
77,350
77,830
77,830
96,945
96,945
96,945
96,94596,94596,94577,83077,83077,35077,35077,35077,35077,35077,35077,35077,35077,35077,35077,350
   Retained Earnings 
70,558
74,397
82,165
92,295
103,071
131,868
170,016
178,928
247,517
356,997
435,115
659,283
883,696
936,843
1,885,547
2,686,374
2,686,3741,885,547936,843883,696659,283435,115356,997247,517178,928170,016131,868103,07192,29582,16574,39770,558
   Accumulated Other Comprehensive Income 
-50,320
-62,579
-73,755
-87,792
-101,894
-116,719
-141,290
-215,979
-250,388
-287,211
-79,106
-124,989
-207,186
700,578
708,687
708,234
708,234708,687700,578-207,186-124,989-79,106-287,211-250,388-215,979-141,290-116,719-101,894-87,792-73,755-62,579-50,320
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
65,041
77,300
88,475
102,513
116,615
131,440
156,011
230,700
265,109
301,932
101,800
141,355
-606,208
700,578
708,687
-2,783,319
-2,783,319708,687700,578-606,208141,355101,800301,932265,109230,700156,011131,440116,615102,51388,47577,30065,041



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue6,906,208
Cost of Revenue-3,318,204
Gross Profit3,588,0043,588,004
 
Operating Income (+$)
Gross Profit3,588,004
Operating Expense-2,464,301
Operating Income1,153,3091,123,703
 
Operating Expense (+$)
Research Development51,859
Selling General Administrative880,686
Selling And Marketing Expenses59,562
Operating Expense2,464,301992,107
 
Net Interest Income (+$)
Interest Income82,233
Interest Expense-82,233
Other Finance Cost-82,233
Net Interest Income-82,233
 
Pretax Income (+$)
Operating Income1,153,309
Net Interest Income-82,233
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,067,2091,239,409
EBIT - interestExpense = 1,067,209
1,067,209
879,281
Interest Expense82,233
Earnings Before Interest and Taxes (EBIT)1,149,4421,149,442
Earnings Before Interest and Taxes (EBITDA)1,372,252
 
After tax Income (+$)
Income Before Tax1,067,209
Tax Provision-270,161
Net Income From Continuing Ops797,048797,048
Net Income797,048
Net Income Applicable To Common Shares797,048
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,782,505
Total Other Income/Expenses Net-86,10082,233
 

Technical Analysis of Gufic
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gufic. The general trend of Gufic is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gufic's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Gufic Biosciences Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 298.80 < 305.70 < 325.85.

The bearish price targets are: 277.65 > 259.75 > 238.02.

Tweet this
Gufic Biosciences Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Gufic Biosciences Limited. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Gufic Biosciences Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Gufic Biosciences Limited. The current macd is -8.90814059.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gufic price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Gufic. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Gufic price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Gufic Biosciences Limited Daily Moving Average Convergence/Divergence (MACD) ChartGufic Biosciences Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Gufic Biosciences Limited. The current adx is 22.71.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Gufic shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Gufic Biosciences Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Gufic Biosciences Limited. The current sar is 279.04.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Gufic Biosciences Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Gufic Biosciences Limited. The current rsi is 35.78. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Gufic Biosciences Limited Daily Relative Strength Index (RSI) ChartGufic Biosciences Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Gufic Biosciences Limited. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Gufic price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Gufic Biosciences Limited Daily Stochastic Oscillator ChartGufic Biosciences Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Gufic Biosciences Limited. The current cci is -102.60401225.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Gufic Biosciences Limited Daily Commodity Channel Index (CCI) ChartGufic Biosciences Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Gufic Biosciences Limited. The current cmo is -32.35811197.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Gufic Biosciences Limited Daily Chande Momentum Oscillator (CMO) ChartGufic Biosciences Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Gufic Biosciences Limited. The current willr is -82.70944742.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Gufic Biosciences Limited Daily Williams %R ChartGufic Biosciences Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Gufic Biosciences Limited.

Gufic Biosciences Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Gufic Biosciences Limited. The current atr is 11.71.

Gufic Biosciences Limited Daily Average True Range (ATR) ChartGufic Biosciences Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Gufic Biosciences Limited. The current obv is 12,454,151.

Gufic Biosciences Limited Daily On-Balance Volume (OBV) ChartGufic Biosciences Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Gufic Biosciences Limited. The current mfi is 50.51.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Gufic Biosciences Limited Daily Money Flow Index (MFI) ChartGufic Biosciences Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Gufic Biosciences Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Gufic Biosciences Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Gufic Biosciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.784
Ma 20Greater thanMa 50297.505
Ma 50Greater thanMa 100319.316
Ma 100Greater thanMa 200315.590
OpenGreater thanClose286.750
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Gufic with someone you think should read this too:
  • Are you bullish or bearish on Gufic? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gufic? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Gufic Biosciences Limited

I send you an email if I find something interesting about Gufic Biosciences Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Gufic Biosciences Limited.

Receive notifications about Gufic Biosciences Limited in your mailbox!